Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Wong Mito Lab, |
RCV000853749 | SCV000996782 | benign | Leigh syndrome | 2019-10-17 | criteria provided, single submitter | clinical testing | The NC_012920.1:m.4216T>C (YP_003024026.1:p.Tyr304His) variant in MTND1 gene is interpretated to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: BA1 |
Breakthrough Genomics, |
RCV000709875 | SCV005277495 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000010373 | SCV000030599 | pathogenic | Leber optic atrophy | 1992-09-30 | no assertion criteria provided | literature only | |
Gene |
RCV000010373 | SCV000087256 | unknown | Leber optic atrophy | 2013-09-19 | no assertion criteria provided | curation | Converted during submission to Uncertain significance. |
Genome |
RCV000709875 | SCV000840212 | not provided | not provided | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |